Histidine Triad Proteins in Neuropathy and Cancer

In eukaryotic cells, histidine triad proteins constitute a conserved enzyme superfamily defined by a signature H–X–H–X–H–X–X motif that binds nucleotides and mediates a range of cellular processes. Among these, the nucleotide-binding protein HINT1 has emerged as a dual regulator of neuronal integrity and tumour suppression. In the peripheral nervous system, loss-of-function mutations in HINT1 produce an autosomal recessive axonal neuropathy with neuromyotonia, indicating a critical role in axonal maintenance and ion channel regulation. In parallel, HINT1 exerts tumour-suppressive effects by interacting with key transcription factors, such as β-catenin and microphthalmia-associated transcription factor (MITF), thereby modulating gene networks that control cell proliferation and apoptosis. Beyond HINT1, related proteins including HINT2 influence mitochondrial homeostasis and epithelial-to-mesenchymal transition, linking histidine triad enzymes to vascularisation, metabolic control and metastatic potential. Recent advances illuminate how post-translational modifications, small-molecule mediators and genetic variants converge on histidine triad proteins to shape both nervous system function and cancer progression, underscoring their therapeutic promise across disciplines.

Research from Nature Portfolio

Recent studies have revealed a direct signalling mechanism whereby the second messenger Ap4A binds HINT1 and induces a polymeric assembly that displaces associated transcription factors. High-resolution structures demonstrate that Ap4A-mediated polymerisation occludes the transcription factor interface on HINT1, thereby releasing MITF and promoting downstream gene expression in activated immune cells. This chemical-induced conformational switch highlights a non-enzymatic regulatory mode for histidine triad proteins and establishes a paradigm for small-molecule control of transcriptional networks through protein polymer models.

Histidine Triad Proteins in Neuropathy and Cancer publication trend

The graph below shows the total number of articles in histidine triad proteins in neuropathy and cancer across all publications each year (not limited to Nature Index journals).

Technical terms

Histidine triad protein: Enzyme family characterised by a conserved H–X–H–X–H–X–X motif that binds nucleotides and mediates hydrolytic or regulatory functions.

Adenylate tetraphosphate (Ap4A): A small nucleotide second messenger that interacts with signalling proteins to modulate cellular responses.

Polymerisation: Assembly of protein monomers into higher-order structures that alter their functional interfaces.

Transcription factor: Protein that binds specific DNA sequences to regulate gene expression.

Epithelial-to-mesenchymal transition (EMT): Cellular programme by which epithelial cells acquire migratory and invasive properties, often implicated in metastasis.

References

1. Histidine Triad Nucleotide-Binding Protein 1 Improves Critical Limb Ischemia by Regulating Mitochondrial Homeostasis. Nutrients (2023).
2. Second messenger Ap4A polymerizes target protein HINT1 to transduce signals in FcεRI-activated mast cells. Nature Communications (2019).
3. Deacetylation by SIRT1 promotes the tumor-suppressive activity of HINT1 by enhancing its binding capacity for β-catenin or MITF in colon cancer and melanoma cells. Experimental & Molecular Medicine (2020).
4. HINT2 downregulation promotes colorectal carcinoma migration and metastasis. Oncotarget (2017).
5. HINT1 neuropathy in Norway: clinical, genetic and functional profiling. Orphanet Journal of Rare Diseases (2021).